SCHEMBL7918345

SCHEMBL7918345

C=C(O)c1ccc2cccc(-c3ccccc3Cl)c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.40
CYP2A6 P11509 3/20 0.40
CYP1A1 P04798 2/20 0.37
CYP1B1 Q16678 2/20 0.37
LDHA P00338 1/20 0.36
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
GLA P06280 1/20 0.36
RAB9A P51151 2/20 0.35
RORC P51449 1/20 0.35
RORB Q92753 1/20 0.35
NPC1 O15118 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
F2 P00734 1/20 0.35
PLG P00747 1/20 0.35
PLAU P00749 1/20 0.35
PLAT P00750 1/20 0.35
KLK1 P06870 1/20 0.35
PRSS1 P07477 1/20 0.35
MIF P14174 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16502458 0.84 PLA2G2D (0.49) KDM4ERAB9ANPC1SMN1; SMN2MAP4K4
SCHEMBL16503576 0.82 HSP90AA1 (0.35) CYP1A2CYP2A6CYP1A1CYP1B1KDM4E
SCHEMBL7920129 0.82 TNF (0.45) CYP1A2KDM4EALDH1A1SMN1; SMN2F2
SCHEMBL7916817 0.81 AKR1C3 (0.41) CYP1A2CYP1A1CYP1B1KDM4ERAB9A
SCHEMBL16503471 0.80 DOT1L (0.39) KDM4EALDH1A1RORCRORBSMN1; SMN2
SCHEMBL7916768 0.79 KDM4E (0.38) CYP1A1CYP1B1KDM4ERAB9ARORC
SCHEMBL7906715 0.78 MAPT (0.41) KDM4EALDH1A1RAB9ASMN1; SMN2PLAU
SCHEMBL7906709 0.78 CA1 (0.41) CYP1A2KDM4EKMT2ACYP2C19
SCHEMBL16502432 0.77 MAPT (0.48) CYP1A2KDM4EALDH1A1GLARAB9A
SCHEMBL7915836 0.76 GRM2 (0.35) RORCF2PLGPLAUPLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010090304-A1 ACYLGUANIDINE DERIVATIVE アステラス製薬株式会社 (JP) 2010-08-12 WO disclosed